Luken Investment Analytics’s Eli Lilly LLY Stock Holding History

Luken Investment Analytics’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$573K	Hold	478	–	–	0.2%	45
2026 Q1	$440K	Sell	478 -5	-1%	-$5.07K	0.17%	46
2025 Q4	$519K	Sell	483 -87	-15%	-$83.2K	0.2%	37
2025 Q3	$435K	Hold	570	–	–	0.17%	41
2025 Q2	$444K	Sell	570 -14	-2%	-$10.9K	0.19%	39
2025 Q1	$482K	Buy	584 +14	+2%	+$11.6K	0.23%	34
2024 Q4	$440K	Hold	570	–	–	0.2%	34
2024 Q3	$505K	Hold	570	–	–	0.23%	31
2024 Q2	$516K	Hold	570	–	–	0.26%	34
2024 Q1	$443K	Sell	570 -100	-15%	-$71.2K	0.22%	32
2023 Q4	$391K	Hold	670	–	–	0.21%	34
2023 Q3	$360K	Hold	670	–	–	0.21%	35
2023 Q2	$314K	Hold	670	–	–	0.18%	35
2023 Q1	$230K	Buy	670 +11	+2%	+$3.71K	0.14%	38
2022 Q4	$241K	Buy	+659	New	+$234K	0.15%	35
2020 Q4	$73K	Buy	+435	New	+$64.9K	0.05%	46

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Luken Investment Analytics's LLY Position: Q2 2026 in Review

Luken Investment Analytics held its Eli Lilly (LLY) position steady in Q2 2026 at 478 shares worth $573K. The position accounts for 0.2% of the portfolio, ranked #45.

Luken Investment Analytics first reported a position in LLY in Q4 2020 and has held it in 16 quarters since. 4,637 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Luken Investment Analytics held 478 shares of Eli Lilly worth $573K as of Q2 2026.
Luken Investment Analytics left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 0.2% of Luken Investment Analytics's portfolio in Q2 2026, its #45 holding.
Luken Investment Analytics first reported a position in Eli Lilly in Q4 2020 and has held it in 16 quarters since.
4,637 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Luken Investment Analytics's 13F filing for Q2 2026, filed 28 Jul 2026.